High pretreatment platelet-to-lymphocyte ratio is related to poor prognosis in the squamous cell carcinoma of the larynx and hypopharynx in male patients

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Perri F, Ionna F, Longo F, et al. Immune response against head and neck cancer: biological mechanisms and implication on therapy. Transl Oncol. 2020;13(2):262–274.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953.
   PubMed Web of Science ®Google Scholar
• van Es N, Sturk A, Middeldorp S, et al. Effects of cancer on platelets. Semin Oncol. 2014;41(3):311–318.
   PubMed Web of Science ®Google Scholar
• Marchi F, Missale F, Incandela F, et al. Prognostic significance of peripheral T-cell subsets in laryngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2019;4(5):513–519.
   PubMed Web of Science ®Google Scholar
• Song PP, You CG. Clinical application values of neutrophil to lymphocyte and platelet to lymphocyte ratios in multiple cancers. Clin Lab. 2020;66:1027–1032.
   Web of Science ®Google Scholar
• Bardash Y, Olson C, Herman W, et al. Platelet-lymphocyte ratio as a predictor of prognosis in head and neck cancer: a systematic review and meta-analysis. Oncol Res Treat. 2019;42(12):665–677.
   PubMed Web of Science ®Google Scholar
• Yang L, Huang Y, Zhou L, et al. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: systematic review and meta-analysis. Head Neck. 2019;41(5):1525–1535.
   PubMed Web of Science ®Google Scholar
• Rassouli A, Saliba J, Castano R, et al. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. 2015;37(1):103–110.
   PubMed Web of Science ®Google Scholar
• Bojaxhiu B, Templeton AJ, Elicin O, et al. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Radiat Oncol. 2018;13(1):216.
   PubMed Web of Science ®Google Scholar
• Chen L, Zeng H, Yang J, et al. Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma. BMC Cancer. 2018;18(1):816
   PubMed Web of Science ®Google Scholar
• Tham T, Wotman M, Chung C, et al. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis. Eur Arch Otorhinolaryngol. 2019;276(10):2913–2922.
   PubMed Web of Science ®Google Scholar
• Song S, Chen H, Dong W, et al. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma. Acta Otolaryngol. 2019;139(3):294–298.
   PubMed Web of Science ®Google Scholar
• Cai H, Zhang ZH, Zhou YJ, et al. The prognostic value of preoperative plasma fibrinogen and neutrophil-to-lymphocyte ratio in patients with laryngeal squamous cell carcinoma. Ear Nose Throat J. 2020. DOI: 10.1177/0145561320920746
   Web of Science ®Google Scholar
• Fei Y, Wang X, Zhang H, et al. Reference intervals of systemic immune-inflammation index, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume to platelet ratio, mean platelet volume and red blood cell distribution width-standard deviation in healthy Han adults in Wuhan region in central China. Scand J Clin Lab Invest. 2020;80(6):500–507.
   PubMed Web of Science ®Google Scholar
• Hsueh C, Tao L, Zhang M, et al. The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget. 2017;8(36):60514–60527.
   PubMedGoogle Scholar
• Wang J, Wang S, Song X, et al. The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma. Onco Targets Ther. 2016;9:7177–7185.
   PubMed Web of Science ®Google Scholar
• Mao Y, Fu Y, Gao Y, et al. Platelet-to-lymphocyte ratio predicts long-term survival in laryngeal cancer. Eur Arch Otorhinolaryngol. 2018;275(2):553–559.
   PubMed Web of Science ®Google Scholar
• Lau HC, Hsueh CY, Chen Q, et al. Prognostic values of preoperative platelet-to-lymphocyte ratio and platelet-related indices in advanced hypopharyngeal squamous cell carcinoma. Clin Otolaryngol. 2020;45(2):221–230.
   PubMed Web of Science ®Google Scholar
• Sun W, Huang JQ, Chen L, et al. Peripheral inflammation markers of chemosensitivity to induction chemotherapy in hypopharyngeal cancer patients. ORL J Otorhinolaryngol Relat Spec. 2019;81(2–3):82–91.
   PubMed Web of Science ®Google Scholar